Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Voyager Therapeutics, Inc. - Common Stock
(NQ:
VYGR
)
3.110
-0.300 (-8.80%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Voyager Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Earnings Outlook For Voyager Therapeutics
November 03, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
September 18, 2023
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
July 17, 2023
Via
Benzinga
2 Biotech Stocks That Could Make You Richer
July 14, 2023
These biotech companies are seeing a spike in revenue growth.
Via
The Motley Fool
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
July 11, 2023
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.
Via
InvestorPlace
Earnings Preview For Voyager Therapeutics
May 08, 2023
Via
Benzinga
Earnings Outlook For Voyager Therapeutics
March 06, 2023
Via
Benzinga
Why Voyager Therapeutics Stock Is Sinking This Week
January 20, 2023
Investors are taking profits on this red-hot stock this week.
Via
The Motley Fool
Confidence Boost From Ingrezza Sales: Analyst Upgrades Neurocrine Biosciences
July 06, 2023
BMO Capital Markets has upgraded Neurocrine Biosciences Inc (NASDAQ: NBIX) from Underperform to Market Perform, with a price target of $96,
Via
Benzinga
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 21, 2023
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...
Via
Benzinga
The 7 Best Stocks Under $15 to Buy in June 2023
June 01, 2023
While you generally get what you pay for, these best stocks under $15 for June provide compelling opportunities at discount.
Via
InvestorPlace
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 23, 2023
Gainers
Via
Benzinga
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday
May 23, 2023
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Top 5 Health Care Stocks That Should Keep You Up At Night
May 23, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Voyager Therapeutics' Seasoned Management And Leading Adeno-Associated Virus Capsid Platform Impress Bullish Analyst
May 10, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
May 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 09, 2023
Via
Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
May 09, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
March 10, 2023
Via
Benzinga
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
$39M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
February 27, 2023
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
7 A-Rated Stocks to Buy for Less Than $25
January 24, 2023
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market.
Via
InvestorPlace
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
January 13, 2023
Sharp Tesla price cuts and some notable earnings were in focus.
Via
Investor's Business Daily
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
January 13, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Is Apexigen (APGN) Stock Up 97% Today?
January 09, 2023
Apexigen (APGN) stock is rocketing higher on Monday following new coverage of the company from an analyst and heavy trading.
Via
InvestorPlace
Why Is Party City (PRTY) Stock Up 41% Today?
January 09, 2023
Party City (PRTY) stock is in the news Monday as investors prepare for the celebration goods company to file for bankruptcy.
Via
InvestorPlace
Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal
January 09, 2023
Voyager Therapeutics' lucrative arrangement with a fellow biotech business is putting VYGR stock traders in a buying mood today.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.